Arcadia Biosciences, Inc. (RKDA) Insider Ownership

Data spanning the past 90 days through February 19, 2026 reveals that Arcadia Biosciences's three principal insider shareholders consist of Chief Executive Officer Stanley Jr Jacot (5.00K shares), Chief Executive Officer Thomas J. Schaefer (2.82K shares), Chief Financial Officer Mark Kawakami (2.68K shares).

• Arcadia Biosciences, Inc. (RKDA) exhibits a conventional ownership structure with institutions commanding 2.83% of outstanding shares, insider ownership remaining at 0.82%, and public/other investors holding 96.35%.
• Current insider holdings at Arcadia Biosciences account for 0.82% of total shares outstanding as of February 19, 2026, totaling roughly 11.31K shares from the company's 1.38Mn share base.
• Arcadia Biosciences's count of insider shares amounted to 11.31K as of February 19, 2026.
• There were no significant insider purchasers for Arcadia Biosciences in the last 90 days.
• Arcadia Biosciences had no significant insider sales in the last 90 days.